6
Views
9
CrossRef citations to date
0
Altmetric
Review

Merkel cell carcinoma: what we know now

Pages 345-355 | Published online: 10 Jan 2014

References

  • Briggaman RA, Wheeler CE Jr. The epidermal–dermal junction. J. Invest. Dermatol.65(1), 71–84 (1975).
  • Miettinen M, Lehto VP, Virtanen I, Asko-Seljavaara S, Pitkanen J, Dahl D. Neuroendocrine carcinoma of the skin (Merkel cell carcinoma): ultrastructural and immunohistochemical demonstration of neurofilaments. Ultrastruct. Pathol.4(2–3), 219–225 (1983).
  • Sadahira Y, Nakamoto S, Mori M, Hsueh CL, Awai M. Merkel cell tumor coexpressing cytokeratin and neurofilament proteins. Acta Pathol. Jpn.37(2), 331–337 (1987).
  • Vaigot P, Pisani A, Darmon YM, Ortonne JP. The majority of epidermal Merkel cells are non-proliferative: a quantitative immunofluorescence analysis. Acta Derm. Venereol.67(6), 517–520 (1987).
  • Moll I, Zieger W, Schmelz M. Proliferative Merkel cells were not detected in human skin. Arch Dermatol. Res.288(4), 184–187 (1996).
  • Smith PD, Patterson JW. Merkel cell carcinoma (neuroendocrine carcinoma of the skin). Am. J. Clin. Pathol.115(Suppl.), S68–S78 (2001).
  • Gould E, Albores-Saavedra J, Dubner B, Smith W, Payne CM. Eccrine and squamous differentiation in Merkel cell carcinoma. An immunohistochemical study. Am. J. Surg. Pathol.12(10), 768–772 (1988).
  • Saeb-Lima M, Montante-Montes de Oca D, Albores-Saavedra J. Merkel cell carcinoma with eccrine differentiation: a clinicopathologic study of 7 cases. Ann. Diagn. Pathol.12(6), 410–414 (2008).
  • Toker C. Trabecular carcinoma of the skin. Arch. Derm.105(1), 107–110 (1972).
  • Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer42(5), 2311–2321 (1978).
  • Johannessen JV, Gould VE. Neuroendocrine skin carcinoma associated with calcitonin production: a Merkel cell carcinoma? Hum. Pathol.11(5 Suppl.), 586–588 (1980).
  • Heath M, Jaimes N, Lemos B et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J. Am. Acad. Dermatol.58(3), 375–381 (2008).
  • Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J. Clin. Oncol.23(10), 2300–2309 (2005).
  • Konno A, Nagata M, Nanko H. Immunohistochemical diagnosis of a Merkel cell tumor in a dog. Vet. Pathol.35(6), 538–540 (1998).
  • Glick AD, Holscher MA, Crenshaw JD. Neuroendocrine carcinoma of the skin in a dog. Vet. Pathol.20(6), 761–763 (1983).
  • Patnaik AK, Post GS, Erlandson RA. Clinicopathologic and electron microscopic study of cutaneous neuroendocrine (Merkel cell) carcinoma in a cat with comparisons to human and canine tumors. Vet. Pathol.38(5), 553–556 (2001).
  • Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol. Biomarkers Prev.8(2), 153–158 (1999).
  • Penn I, First MR. Merkel’s cell carcinoma in organ recipients: report of 41 cases. Transplantation68(11), 1717–1721 (1999).
  • Bordea C, Wojnarowska F, Millard PR, Doll H, Welsh K, Morris PJ. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation77(4), 574–579 (2004).
  • Koljonen V, Kukko H, Tukiainen E et al. Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol. Dial. Transplant.24(10), 3231–3235 (2009).
  • Buell JF, Trofe J, Hanaway MJ et al. Immunosuppression and Merkel cell carcinoma. Transplant. Proc.34, 1780–1781 (2002).
  • Koljonen V, Kukko H, Pukkala E et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br. J. Cancer101(8), 1444–1447 (2009).
  • Lawenda BD, Thiringer JK, Foss RD, Johnstone PA. Merkel cell carcinoma arising in the head and neck: optimizing therapy. Am. J. Clin. Oncol.24(1), 35–42 (2001).
  • Popp S, Waltering S, Herbst C, Moll I, Boukamp P. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int. J. Cancer99(3), 352–360 (2002).
  • Tai PT, Yu E, Winquist E et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J. Clin. Oncol.18(12), 2493–2499 (2000).
  • Altman LK. Virus is Linked to a Powerful Skin Cancer. New York Times, 18 January (2008).
  • Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science319(5866), 1096–1100 (2008).
  • Shuda M, Arora R, Kwun HJ et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int. J. Cancer125(6), 1243–1249 (2009).
  • Shuda M, Feng H, Kwun HJ et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl Acad. Sci. USA105(42), 16272–16277 (2008).
  • Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J. Natl Cancer Inst.101(13), 938–945 (2009).
  • Kassem A, Schopflin A, Diaz C et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res.68(13), 5009–5013 (2008).
  • Andres C, Belloni B, Puchta U, Sander CA, Flaig MJ. Prevalence of MCPyV in Merkel cell carcinoma and non-MCC tumors. J. Cutan. Pathol. DOI: 10.1111/j.1600-0560.2009.01352.x (2009) (Epub ahead of print).
  • Becker JC, Houben R, Ugurel S, Trefzer U, Pfohler C, Schrama D. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J. Invest. Dermatol.129(1), 248–250 (2009).
  • Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, Nghiem P. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J. Invest. Dermatol.129(1), 246–248 (2009).
  • Ridd K, Yu S, Bastian BC. The presence of polyomavirus in non-melanoma skin cancer in organ transplant recipients is rare. J. Invest. Dermatol.129(1), 250–252 (2009).
  • Foulongne V, Dereure O, Kluger N, Moles JP, Guillot B, Segondy M. Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br. J. Dermatol.162(1), 59–63 (2009).
  • Duncavage EJ, Zehnbauer BA, Pfeifer JD. Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma. Mod. Pathol.22(4), 516–521 (2009).
  • Sastre-Garau X, Peter M, Avril MF et al. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J. Pathol.218(1), 48–56 (2009).
  • Wetzels CT, Hoefnagel JG, Bakkers JM, Dijkman HB, Blokx WA, Melchers WJ. Ultrastructural proof of polyomavirus in Merkel cell carcinoma tumor cells and its absence in small cell carcinoma of the lung. PLoS ONE, 4(3), e4958 (2009).
  • Varga E, Kiss M, Szabo K, Kemeny L. Detection of Merkel cell polyomavirus DNA in Merkel cell carcinomas. Br. J. Dermatol.161(4), 930–932 (2009).
  • Touze A, Gaitan J, Maruani A et al. Merkel cell polyomavirus strains in patients with merkel cell carcinoma. Emerg. Infect. Dis.15(6), 960–962 (2009).
  • Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW. Merkel cell carcinoma subgroups by merkel cell polyomavirus DNA relative abundance and oncogene expression. Int. J. Cancer126(9), 2240–2246 (2009).
  • Carter JJ, Paulson KG, Wipf GC et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J. Natl Cancer Inst.101(21), 1510–1522 (2009).
  • Leonard JH, Bell JR, Kearsley JH. Characterization of cell lines established from Merkel-cell (‘small-cell’) carcinoma of the skin. Int. J. Cancer55(5), 803–810 (1993).
  • Helmbold P, Lahtz C, Herpel E, Schnabel PA, Dammann RH. Frequent hypermethylation of RASSF1A tumor suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur. J. Cancer45(12), 2207–2211 (2009).
  • Bluemn EG, Paulson KG, Higgins EE, Sun Y, Nghiem P, Nelson PS. Merkel cell polyomavirus is not detected in prostate cancers, surrounding stroma, or benign prostate controls. J. Clin. Virol.44(2), 164–166 (2009).
  • Kassem A, Technau K, Kurz AK et al. Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int. J. Cancer125(2), 356–361 (2009).
  • Dworkin AM, Tseng SY, Allain DC, Iwenofu OH, Peters SB, Toland AE. Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J. Invest. Dermatol.129(12), 2868–2874 (2009).
  • Tarkkanen M, Knuutila S. The diagnostic use of cytogenetic and molecular genetic techniques in the assessment of small round cell tumours. Curr. Diagn. Pathol.8(5), 338–348 (2002).
  • Pisick E, Skarin AT, Salgia R. Recent advances in the molecular biology, diagnosis and novel therapies for various small blue cell tumors. Anticancer Res.23(4), 3379–3396 (2003).
  • Bialasiewicz S, Lambert SB, Whiley DM, Nissen MD, Sloots TP. Merkel cell polyomavirus DNA in respiratory specimens from children and adults. Emerg. Infect. Dis.15(3), 492–494 (2009).
  • Goh S, Lindau C, Tiveljung-Lindell A, Allander T. Merkel cell polyomavirus in respiratory tract secretions. Emerg. Infect. Dis.15(3), 489–491 (2009).
  • Kantola K, Sadeghi M, Lahtinen A et al. Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency. J. Clin. Virol.45(4), 292–295 (2009).
  • Loyo M, Guerrero-Preston R, Brait M et al. Quantitative detection of merkel cell virus in human tissues and possible mode of transmission. Int. J. Cancer126(12), 2991–2996 (2010).
  • Tolstov YL, Pastrana DV, Feng H et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int. J. Cancer125(6), 1250–1256 (2009).
  • Van Gele M, Kaghad M, Leonard JH et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br. J. Cancer82(4), 823–826 (2000).
  • Koljonen V, Tukiainen E, Haglund C, Bohling T. Cell cycle control by p21, p27 and p53 in Merkel cell carcinoma. Anticancer Res.26(3B), 2209–2212 (2006).
  • Van Gele M, Leonard JH, Van Roy N, Cook AL, De Paepe A, Speleman F. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma. Int. J. Cancer92(3), 409–413 (2001).
  • Liu S, Daa T, Kashima K, Kondoh Y, Yokoyama S. The Wnt-signaling pathway is not implicated in tumorigenesis of Merkel cell carcinoma. J. Cutan. Pathol.34(1), 22–26 (2007).
  • Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene – implications for treatment with imatinib mesylate. J. Cutan. Pathol.34(4), 324–329 (2007).
  • Brunner M, Thurnher D, Pammer J et al. Expression of VEGF-A/C, VEGF-R2, PDGF-α/β, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma. Mod. Pathol.21(7), 876–884 (2008).
  • Houben R, Michel B, Vetter-Kauczok CS et al. Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma. J. Invest. Dermatol.126(5), 1135–1142 (2006).
  • Kennedy MM, Blessing K, King G, Kerr KM. Expression of bcl-2 and p53 in Merkel cell carcinoma. An immunohistochemical study. Am. J. Dermatopathol.18(3), 273–277 (1996).
  • Plettenberg A, Pammer J, Tschachler E. Merkel cells and Merkel cell carcinoma express the BCL-2 proto-oncogene. Exp. Dermatol.5(3), 183–188 (1996).
  • Tucci MG, Lucarini G, Giangiacomi M et al. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma. J. Eur. Acad. Dermatol. Venereol.20(10), 1220–1225 (2006).
  • Coleman NM, Smith-Zagone MJ, Tanyi J et al. Primary neuroendocrine carcinoma of the vagina with Merkel cell carcinoma phenotype. Am. J. Surg. Pathol.30(3), 405–410 (2006).
  • Sur M, Alardati H, Ross C, Alowami S. TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis. Mod. Pathol.20(11), 1113–1120 (2007).
  • Schlagbauer-Wadl H, Klosner G, Heere-Ress E et al. Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice. J. Invest. Dermatol.114(4), 725–730 (2000).
  • Shah MH, Varker KA, Collamore M et al. G3139 (Genasense) in patients with advanced merkel cell carcinoma. Am. J. Clin. Oncol.32(2), 174–179 (2009).
  • Hodgson NC. Merkel cell carcinoma: changing incidence trends. J. Surg. Oncol.89(1), 1–4 (2005).
  • Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J. Clin.48(1), 6–29 (1998).
  • Howard RA, Dores GM, Curtis RE, Anderson WF, Travis LB. Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol. Biomarkers Prev.15(8), 1545–1549 (2006).
  • Schmid C, Beham A, Feichtinger J, Aubock L, Dietze O. Recurrent and subsequently metastasizing Merkel cell carcinoma in a 7-year-old girl. Histopathology20(5), 437–439 (1992).
  • Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J. Cutan. Pathol. 10.1111/j.1600-0560.2009.01370.x (2009) (Epub ahead of print).
  • Lanoy E, Dores GM, Madeleine MM, Toro JR, Fraumeni JF Jr, Engels EA. Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. AIDS23(3), 385–393 (2009).
  • Gupta SG, Wang LC, Penas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch. Dermatol.142(6), 685–690 (2006).
  • Poulsen M. Merkel cell carcinoma of skin: diagnosis and management strategies. Drugs Aging22(3), 219–229 (2005).
  • Dancey AL, Rayatt SS, Soon C, Ilchshyn A, Brown I, Srivastava S. Merkel cell carcinoma: a report of 34 cases and literature review. J. Plast. Reconstr. Aesthet. Surg.59(12), 1294–1299 (2006).
  • Walsh NM. Primary neuroendocrine (Merkel cell) carcinoma of the skin: morphologic diversity and implications thereof. Hum. Pathol.32(7), 680–689 (2001).
  • Brenner B, Sulkes A, Rakowsky E et al. Second neoplasms in patients with Merkel cell carcinoma. Cancer91(7), 1358–1362 (2001).
  • Ziprin P, Smith S, Salerno G, Rosin RD. Two cases of merkel cell tumor arising in patients with chronic lymphocytic leukaemia. Br. J. Dermatol.142(3), 525–528 (2000).
  • Sinclair N, Mireskandari K, Forbes J, Crow J. Merkel cell carcinoma of the eyelid in association with chronic lymphocytic leukaemia. Br. J. Ophthalmol.87(2), 240 (2003).
  • Bedane C, Clavere P, Lavignac C, Labrousse F, Olivier JP, Bonnetbalnc JM. [Neuroendocrine primary cutaneous carcinoma. Therapeutic aspects in 13 patients]. Ann. Dermatol. Venereol.123(8), 443–446 (1996).
  • Cerroni L, Kerl H. Primary cutaneous neuroendocrine (Merkel cell) carcinoma in association with squamous- and basal-cell carcinoma. Am. J. Dermatopathol.19(6), 610–613 (1997).
  • Moll I, Bladt U, Jung EG. Presence of Merkel cells in sun-exposed and not sun-exposed skin: a quantitative study. Arch. Dermatol. Res.282(4), 213–216 (1990).
  • Hartschuh W, Schulz T. Merkel cell hyperplasia in chronic radiation-damaged skin: its possible relationship to fibroepithelioma of Pinkus. J. Cutan. Pathol.24(8), 477–483 (1997).
  • Vieites B, Suarez-Penaranda JM, Delgado V, Vazquez-Veiga H, Varela J, Forteza J. Merkel cell carcinoma associated with in situ and invasive squamous cell carcinoma. Acta Derm. Venereol.89(2), 184–186 (2009).
  • Johansson L, Tennvall J, Akerman M. Immunohistochemical examination of 25 cases of Merkel cell carcinoma: a comparison with small cell carcinoma of the lung and oesophagus, and a review of the literature. APMIS98(8), 741–752 (1990).
  • Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am. J. Pathol.140(2), 427–447 (1992).
  • Ralston J, Chiriboga L, Nonaka D. MASH1: a useful marker in differentiating pulmonary small cell carcinoma from Merkel cell carcinoma. Mod. Pathol.21(11), 1357–1362 (2008).
  • Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch. Surg.126(12), 1514–1519 (1991).
  • Van Gele M, Boyle GM, Cook AL et al. Gene-expression profiling reveals distinct expression patterns for classic versus variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinoma. Oncogene23(15), 2732–2742 (2004).
  • Anderson SE, Beer KT, Banic A et al. MRI of merkel cell carcinoma: histologic correlation and review of the literature. AJR Am. J. Roentgenol.185(6), 1441–1448 (2005).
  • Tsang G, O’Brien P, Robertson R, Hamilton C, Wratten C, Denham J. All delays before radiotherapy risk progression of Merkel cell carcinoma. Australas. Radiol.48(3), 371–375 (2004).
  • Swann MH, Yoon J. Merkel cell carcinoma. Semin. Oncol.34(1), 51–56 (2007).
  • Pectasides D, Pectasides M, Economopoulos T. Merkel cell cancer of the skin. Ann. Oncol.17(10), 1489–1495 (2006).
  • Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J. Am. Acad. Dermatol.49(5), 832–841 (2003).
  • Fernandez-Figueras MT, Puig L, Musulen E et al. Expression profiles associated with aggressive behavior in Merkel cell carcinoma. Mod. Pathol.20(1), 90–101 (2007).
  • Kim J, McNiff JM. Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma. Mod. Pathol.21(6), 764–769 (2008).
  • Koljonen V, Tukiainen E, Haglund C, Bohling T. Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma. Histopathology49(5), 551–553 (2006).
  • Asioli S, Righi A, Volante M, Eusebi V, Bussolati G. p63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer110(3), 640–647 (2007).
  • Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol.5(10), 593–599 (2004).
  • Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann. Surg. Oncol.8(3), 204–208 (2001).
  • Stokes JB, Graw KS, Dengel LT et al. Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J. Clin. Oncol.27(23), 3772–3777 (2009).
  • Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer113(9), 2549–2558 (2008).
  • Ng L, Beer TW, Murray K. Vascular density has prognostic value in Merkel cell carcinoma. Am. J. Dermatopathol.30(5), 442–445 (2008).
  • Beer TW, Ng LB, Murray K. Mast cells have prognostic value in Merkel cell carcinoma. Am. J. Dermatopathol.30(1), 27–30 (2008).
  • Goldberg SR, Neifeld JP, Frable WJ. Prognostic value of tumor thickness in patients with merkel cell carcinoma. J. Surg. Oncol.95(8), 618–622 (2007).
  • Sandel HD 4th, Day T, Richardson MS, Scarlett M, Gutman KA. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival? Laryngoscope116(5), 791–795 (2006).
  • Zhan FQ, Packianathan VS, Zeitouni NC. Merkel cell carcinoma: a review of current advances. J. Natl Compr. Canc. Netw.7(3), 333–339 (2009).
  • Ruan JH, Reeves M. A Merkel cell carcinoma treatment algorithm. Arch. Surg.144(6), 582–585 (2009).
  • Migliano E, Monarca C, Rizzo MI, Bucher S. Merkel cell carcinoma: our therapeutic algorithm: treatment of Merkel cell carcinoma. Ann. Surg. Oncol.16(11), 3211–3213 (2009).
  • Koljonen V, Bohling T, Granhroth G, Tukiainen E. Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur. J. Surg. Oncol.29(7), 607–610 (2003).
  • Bajetta E, Celio L, Platania M et al. Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone. Ann. Surg. Oncol.16(11), 2985–2993 (2009).
  • Mehrany K, Otley CC, Weenig RH, Phillips PK, Roenigk RK, Nguyen TH. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol. Surg.28(2), 113–117 (2002).
  • Koljonen V, Suominen S. Sentinel node biopsy in local anaesthesia in patients with head and neck Merkel cell carcinoma. Eur. J. Plast. Surg.30(5), 205–210 (2008).
  • Allen PJ, Busam K, Hill AD, Stojadinovic A, Coit DG. Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer92(6), 1650–1655 (2001).
  • Rodrigues LK, Leong SP, Kashani-Sabet M, Wong JH. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J. Am. Acad. Dermatol.45(2), 303–308 (2001).
  • Pan D, Narayan D, Ariyan S. Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases. Plast. Reconstr. Surg.110(5), 1259–1265 (2002).
  • Schmalbach CE, Lowe L, Teknos TN, Johnson TM, Bradford CR. Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch. Otolaryngol. Head Neck Surg.131(7), 610–614 (2005).
  • Maza S, Trefzer U, Hofmann M et al. Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur. J. Nucl. Med. Mol. Imaging33(4), 433–440 (2006).
  • Shnayder Y, Weed DT, Arnold DJ et al. Management of the neck in Merkel cell carcinoma of the head and neck: University of Miami experience. Head Neck30, 1559–1565 (2008).
  • Warner RE, Quinn MJ, Hruby G, Scolyer RA, Uren RF, Thompson JF. Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann. Surg. Oncol.15(9), 2509–2518 (2008).
  • Pozo L, Sanchez-Carrillo JJ, Martinez A, Blanes A, Diaz-Cano SJ. Differential kinetic features by tumor topography in cutaneous small-cell neuroendocrine (Merkel cell) carcinomas. J. Eur. Acad. Dermatol. Venereol.21(9), 1220–1228 (2007).
  • Poulsen M, Round C, Keller J, Tripcony L, Veness M. Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb – a review of 60 cases. Int. J. Radiat. Oncol. Biol. Phys.76(2), 393–397 (2009).
  • Poulsen MG, Rischin D, Porter I et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int. J. Radiat. Oncol. Biol. Phys.64(1), 114–119 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.